Search

everythinglearnresearchcommunity

for

Search:↓

The combined treatment of Finasteride and Doxazosin affects prostate tissue by reducing cell growth and altering hormone levels.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Oral prednisolone helps hair regrowth in alopecia areata.

Baricitinib works better than methotrexate for severe alopecia areata.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Pentoxifylline effectively improves pretibial pruritic papular dermatitis.

Pulse corticosteroids help regrow hair in alopecia areata but have side effects, especially betamethasone.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Latanoprost may be a promising new treatment for hair loss.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Testosterone with dutasteride improves muscle strength and body composition in trans men.

Spironolactone helps reduce hospital visits and death from heart issues, lowers blood pressure, but has unclear effects on heart failure with normal heart pump function and can cause high potassium and breast enlargement in men.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

Combining fat grafts with botulinum toxin helps improve Raynaud's symptoms.

Finasteride may reduce prostate cancer risk.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Tofacitinib may help treat hair loss in children with alopecia areata.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

The compounded topical solution is safe, stable, and effective for personalized alopecia treatment.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Adequate steroid treatment needed to limit bone loss in PMR patients.

A new combination of tadalafil and finasteride improves drug performance and stability.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

A man had a rare skin reaction from a hair loss medication, which improved after stopping the drug.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.